Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 3 10Phase NA 4Phase 1/2 2Phase 2/3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 328INDUSTRY 285NIH 48OTHER_GOV 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Astrocytoma 29Central Nervous System Neoplasms 28Unspecified Adult Solid Tumor, Protocol Specific 18Ovarian Neoplasms 17Oligodendroglioma 17Medulloblastoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Lung Neoplasms 15Optic Nerve Glioma 14Neuroblastoma 14Lymphoma 14Carcinoma, Non-Small-Cell Lung 14Leukemia 13Glioblastoma 13Familial ependymoma 12Choroid Plexus Neoplasms 12Carcinoma, Ovarian Epithelial 12Fallopian Tube Neoplasms 11Burkitt Lymphoma 11Breast Neoplasms 11Sarcoma 10Colorectal Neoplasms 9Brain Neoplasms 9Recurrence 8Lymphoma, Large B-Cell, Diffuse 8Brenner Tumor 8Lymphoma, Non-Hodgkin 7Glioma 7Colonic Neoplasms 7Uterine Cervical Neoplasms 6

Interventions

ganitumab 1Radiotherapy, Conformal 1Gemcitabine 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × NETWORK × Pancreatic Neoplasms × Clear all
NCT01298401 2015-11-17

Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas

Radiation Therapy Oncology Group

Phase 1 Completed
8 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡